Patients | Keeping pharma's end user at the centre

News

Eisai unveils digital platform for kidney cancer patients

Eisai has launched a 'digital destination', called Kompass, that aims to support patients after they have been given a diagnosis of kidney cancer.

News

Joy as NICE changes tack on first NHS vitiligo treatment

NHS patients in England with vitiligo will soon be able to access Incyte's Opzelura, the first drug shown to reverse the skin-lightening disorder.

News

FDA maps new regulatory route for ultra-rare diseases

The FDA has sketched out its 'plausible mechanism' regulatory pathway for individualised therapies that treat ultra-rare diseases.

News

Patients struggling with NHS complexity, says report

For patients and GPs, accessing NHS services can feel like a "maze of dead ends and detours," according to a new poll.

News

Woman on crutches, left-hand side of her body, face not revealed

UK firm steps in to ease medicine supply crisis in NHS

Amid reports that a shortage of bone cement in the UK is leading to delayed orthopaedic surgeries, Biocomposites has brought forward a product launch.

Views & Analysis

FCS: A life-limiting condition

GP Karishma Patel tells us about the daily challenges of living with the ultra-rare condition Familial Chylomicronaemia Syndrome (FCS), which prevents the body from breaking down fats.

News

GSK’s TB vaccine makes a big step forward towards licensing

Views & Analysis

eyeforpharma Patient Summit Europe roundup

eyeforpharma's Patient Summit Europe brought together leading patient innovators from industry and patient associations for two days of sharing, learning and a healthy dose

News

Eisai unveils digital platform for kidney cancer patients

Eisai has launched a 'digital destination', called Kompass, that aims to support patients after they have been given a diagnosis of kidney cancer.

News

Joy as NICE changes tack on first NHS vitiligo treatment

NHS patients in England with vitiligo will soon be able to access Incyte's Opzelura, the first drug shown to reverse the skin-lightening disorder.

Press Releases

Digital

Partner Content

Newel Health awarded $2.5M Michael J. Fox research grant

Newel Health has been awarded a $2.5 million research grant from The Michael J. Fox Foundation.

Partner Content

Partner Content

The RARE Youth Revolution has begun

RARE Revolution Magazine proudly launches dedicated RARE youth online platform

Views & Analysis

Patients

Sponsored

7 Strategies for fixing pharma's outdated patient engagement...

The term 'patient centricity' has undergone a radical evolution over recent years.

Patients

Psychiatrist with patient in talking session

Patient centricity in psychiatric management: Bipolar I

Discover what clinicians can do to foster more patient-centred psychiatric care in a Q&A with neuropsychiatric physician assistant Rebecca Barbee.

Deep Dive

Patients

How to land a deal with big pharma

Patients

When drug prices collide: How US policy shifts are hitting p...

Patients

What’s powering the next wave of life sciences investment in...

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Patients

Sponsored

Unlocking the Power of Storytelling in Medical Publications

In this era of accelerating information, it is more critical than ever to be clear and engaging in medical publications – and that increasingly involves the skill of scientific storytelling

Patients

Sponsored

Voices to Trials: Engaging Patients in Clinical Trial Design

To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho

Patients

Sponsored

Measuring the intangible – what is the true value of a “pati...

Podcasts

Patients

pharmaphorum podcast Episode 244, Jeff Harper, Intelliguard

On addressing drug waste and ensuring access, with Jeff Harp...

The rising cost of drugs in 2025 was driven by several factors, including inflation, supply chain issues, and the demand for specialty drugs.

Patients

pharmaphorum podcast Episode 237, Vinay Patel

Rethinking prescription drug affordability, with Vinay Patel

Vinay Patel, an innovative pharmacist, discuss the intricacies of drug pricing and accessibility in the US.

Patients

pharmaphorum podcast Episode 234, Amy Bucher, Lirio

Delivering the right behavioural ingredients for the moment,...

Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.

Video

Patients

Interview at JPM26 with Alexander Schneider

New hope for ovarian cancer, with Alexander Schneider

Alexander Schneider, CEO of CureLab Oncology, shares how his company’s drug candidate for platinum-resistant ovarian cancer is named after his wife.

Patients

Precision medicine in action, with Cary Claiborne

Cary Claiborne, CEO of Adial Pharmaceuticals, discusses his company’s bet on a precision treatment for AUD.

Patients

pharmaphorum with Repronovo's Jean Duvall during JPM2026

Bringing parity to infertility, with Jean Duvall

During JPM2026, pharmaphorum spoke with Jean Duvall, CEO of Repronovo, a company that’s working on new infertility treatments for men and women.

White Papers

Oncology

Sponsored

Patient Centricity to Integration: Enhancing Cancer Outcomes

We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.

Debates & Insight

Sponsored

An integrated digital ecosystem to support patient outcomes,...

Demand for improved pharmaceutical care that enhances the patient experience is ever increasing, and meanwhile outcomes-based medicine has become a key focus for health authorities around the world

Debates & Insight

Sponsored

Patient centricity: How does Boehringer Ingelheim UK measure...

Patient centricity is a subject that is massively talked about but few can 'walk the talk'.

Event

Patients

Partner Content

Operationalize: Expanded Access Programs comes to the West C...

Improving Global Access to Life-Changing Therapeutics...

Patients

Reuters Pharma Barcelona 2023

The Reuters Pharma 2023 event is live in Barcelona and pharmaphorum is on site to provide readers with rolling coverage of the speakers and concepts as unfolds over the next few days.

Patients

Sponsored

Measuring the intangible – what is the true value of a “pati...

Views & Analysis

Words, inclusivity, and the struggle for health equality

Outdated or offensive terminology can reinforce barriers to clinical trial participation and accessible healthcare.

Views & Analysis

Sponsored

Understanding blockchain – a practical guide for life scienc...

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in distributed ledger technology (DLT) on the rise, then it would appear that momentum is b

Partner Content

Patients

Partner Content

Patient Recruitment for Rare Disease Trials Summit

Recruiting patients for rare disease trials is akin to finding a needle in a haystack, with challenges such as geographical dispersion, low awareness, and limited eligible patient pools.

Patients

Partner Content

How walking in a patient's shoes adds value to your patient ...

Imagine the difference it would make if everyone in your organisation had firsthand experience of living with one of the conditions you help treat. What insights would you gain?

Patients

Partner Content

The PM Society – Giving Back

The PM Society is a not-for-profit organisation with 40 years of Giving Back.

News

Press Releases

Views & Analysis

Editor's Picks

Deep Dive

Webinars

Podcasts

Video

White Papers

Event

Debates & Insight

Partner Content

Editor's Picks